Dr. L. Rohit Reddy
MD, DM, ECMO, FAGE (Medical Oncology)
Consultant Medical Oncologist & Hemato Oncologist
Languages:
Telugu, Hindi, English
Telugu, Hindi, English
Med Reg No:
Location:
Malakpet
Dr. L. Rohit Reddy is a well-known Consultant Medical Oncologist & Hemato Oncologist in Hyderabad. He received his education at the All India Institute of Medical Sciences in New Delhi, India’s top-ranked medical school, and completed his training under eminent professors and doctors. He previously received his training in internal medicine at Kasturba Medical College in Manipal, an esteemed medical facility in India.
Dr. L. Rohit Reddy is a pioneer in cancer research and an expert oncologist who specialises in the diagnosis, planning, management, and treatment of all cancers. He advocates for assisting cancer patients in leading fulfilling lives and prioritises patient communication as the most crucial component of cancer care.
Educational Qualifications
- 2019-2022: DM, Medical Oncology, All India Institute of Medical Sciences, New Delhi
- 2015-2018: MD, Internal Medicine, Kasturba Medical College, Manipal, Karnataka
- 2008-2014: MBBS, Kamineni Institute of Medical Sciences, Narketpally, Telangana
Experience
- Jan 2019-Jan 2022: DM, Medical Oncology, All India Institute of Medical Sciences, New Delhi
- May 2015- May 2018: MD, Internal Medicine, Kasturba Medical College, Manipal, Karnataka, India
- April 2013-April 2014: Compulsory Rotatory Internship, Medical Internee, Gandhi Medical College, Secunderabad, India
Services offered
- Diagnosing Cancer
- Tumour Board
- Hemato Oncology Services
- Hematopoietic Stem Cell Transplant and Other Cellular Therapies
- Chemotherapy, Targeted Therapy
- Immunotherapy
- Cancer/Familial Screening Services
- Palliative Counselling and Treatment
- Cancer Genetic Counselling
- Holistic Cancer Care
Special Interest and Expertise
- Treating Benign and Malignant Hematologic Disorders (including Hematopoietic Stem Cell Transplant & Mismatch Transplant)
- Gynecologic (Ovary, Cervix, Endometrium, GTN) and Genitourinary Cancers (Prostate, Renal, Bladder)
- Gastrointestinal Cancers (Esophagus, Stomach, Colorectal, Hepatopancreatobiliary Cancers)
- Thoracic Oncology
- Breast Oncology
- Sarcoma
- Cancer Screening
- Preventive Oncology
- Won Best Poster Award at CIDSCON, Nagpur, 2017
- Won Best Poster Award at APICON, Mumbai, 2017
- Won 1st Prize at Quiz Competition at National level at APICON, Mumbai, 2017
- Received Scholarship Grants for participating in various International Meets such as Leukemia, Lymphoma and Myeloma Conference, New York, October 2021 (Scholarship Award) (Virtual), European Society of Medical Oncology, 2021 (International Cancer Foundation Grant) (Virtual), Society of Hematologic Oncology, Texas, USA, Sept 2021 (Young Investigator Program Travel Grant), European Hematologic Association, Annual Meet, July 2021 (Virtual), HOPE Asia, Sri Lanka, Asia, 2020
- Recipient of YIP Travel Grant SOHO, Texas, USA, 2022
- Recipient of Travel Grant for European Hematology Association, Annual Conference, Vienna, Austria, 2022
- Honors in Anatomy, Biochemistry, Pathology, Microbiology, Ophthalmology, ENT, Obstetrics & Gynecology
- Member of American Society of Clinical Oncology (ASCO)
- Member of European Society of Medical Oncology (ESMO)
- Member of European Society of Hematology (EHA)
- Member of Society of Hemato-Oncology, USA (SOHO)
- Trainee Reviewer at Indian Journal of Medical and Paediatric Oncology (IJMPO)
- Member of Indian Cooperative Oncology Network (ICON)
- Reddy LR, Rasheed AA, Rastogi S. The Evolving Role of Precision Medicine in the Management of Advanced Sarcomas-A Mini Review. Int J Mol Immuno Oncol, doi: 10.25259/IJMIO_6_2021
- Sharma A, Biswas B, Reddy R, Thumbudorai R, Ganguly S, Dabkara D, Pramanik R, Kumar S, Sahoo RK, Sharma A, Kumar L. Seminomatous and Non-Seminomatous Mediastinal Germ Cell Tumors (MGCT): A Real-World Analysis from two Tertiary Care Centers in India.
- Verma S, Reddy R, Chandrashekhara SH, Shamim SA, Tripathy S, Rastogi S. Avapritinib in Advanced Gastrointestinal Stromal Tumor: Case Series and Review of the Literature from a Tertiary Care Center in India. Future Science OA. 2020 Dec(0):FSO676.
- Varma M, Reddy LR, Vidyasagar S, Holla A, Bhat NK. Risk Factors for Carbapenem Resistant Enterobacteriaceae in a Teritiary Hospital-A Case Control Study. Indian Journal Of Medical Specialities. 2018 Oct 1;9(4):178-83.
- Weber SF, Bélard S, Rai S, Reddy R, Belurkar S, Saravu K. Immune Thrombocytopenia Secondary to Tuberculosis: A Case and Review of Literature. The International Journal of Tuberculosis and Lung Disease. 2017 Apr 1;21(4):466-70.
- Bhat N, Vidyasagar S, Reddy R, Holla A. Ranitidine Induced Anaphylaxis. APIK Journal of Internal Medicine. 2016 Jul 1;4(3):36.
- Thesis on “Prognostic Factors and Outcomes of Relapsed Multiple Myeloma treated with Antibody Free Regimes in an Indian Scenario” At AIIMS, Delhi under guidance of Padma Shri, Dr. Lalit Kumar
- Research Project on “Comparison of outcomes between Biochemical Relapse and Clinical Relapse when treated with IMiD-based Triplet”
- Risk Factors and outcomes of Carbapenem Resistant Enterobacteriaceae-A Case Control Study, Thesis Project At KMC, Manipal under guidance of Dr. Muralidhar Verma
- Other Scientific Activities
- Poster: MM-257: It’s the Response That Matters: Real-World Data of Multiple Myeloma Patients Treated without Upfront Stem Cell Transplant Lavu, Rohit Reddy et al. Clinical Lymphoma, Myeloma and Leukemia, Volume 21, S255-Presented at SOHO, Texas, 2021
- Seminomatous and Non-Seminomatous Mediastinal Germ Cell Tumors (MGCT): A Real-World Analysis from two Tertiary Care Centers in India. Aparna Sharma, Bivas Biswas, Rohit Reddy, Robin Thumbudorai, Sandip Ganguly, Deepak Dabkara, Raja Pramanik, Sunil Kumar, Ranjit Kumar Sahoo, Atul Sharma, Lalit Kumar, and Atul Batra, Journal of Clinical Oncology 2021 39:15_suppl, e18726-e18726- e abstract ASCO 2021
- Oral Presentation No. – O-6, titled “Indian Experience with Immunotherapy in Sarcoma and GIST: A Retrospective Study" at IMSOS, India, 2021.
Appointment
Second Opinion
WhatsApp
Call
More
